Hong Kong Gas Utilities Stock News

SEHK:1177
SEHK:1177Pharmaceuticals

Breakthrough Hepatitis B Drug TQA3605 Might Change The Case For Investing In Sino Biopharmaceutical (SEHK:1177)

Sino Biopharmaceutical recently reported that its independently developed Class I innovative drug TQA3605, a core protein allosteric modulator, met the primary endpoint in a randomized, double-blind, placebo-controlled Phase II trial in chronic hepatitis B patients on nucleos(t)ide analogues, significantly improving viral suppression with a generally favorable safety profile. Because no core protein allosteric modulator for hepatitis B is yet approved globally and diagnosis and treatment...
SEHK:3337
SEHK:3337Energy Services

3 Asian Penny Stocks With Market Caps Below US$2B

As global markets navigate a landscape marked by geopolitical uncertainties and economic fluctuations, investors are increasingly turning their attention to Asia's diverse financial ecosystem. Penny stocks, often characterized as smaller or newer companies, continue to capture interest due to their potential for growth and value discovery. While the term may seem outdated, these stocks can offer intriguing opportunities when backed by solid financials and strategic growth plans.
SEHK:939
SEHK:939Banks

A Look At China Construction Bank (SEHK:939) Valuation As Wealth Management Hiring In Hong Kong Accelerates

Wealth management hiring push puts China Construction Bank in focus China Construction Bank (SEHK:939) is back on investors’ radar after its Hong Kong arm outlined plans to hire 100 people over the next two years to grow its wealth management franchise. See our latest analysis for China Construction Bank. The hiring push in Hong Kong comes as China Construction Bank’s shares trade at HK$7.77, with a 30-day share price return of 2.78% but a 90-day share price return showing a 1.65% decline...